SCHEMBL344387

SCHEMBL344387

C=C(C)C(=O)OCCCNC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
THRB P10828 1/20 0.46
POLB P06746 2/20 0.41
APEX1 P27695 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NMT2 O60551 3/20 0.34
NMT1 P30419 3/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
ADRB3 P13945 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.33
ITGB3 P05106 2/20 0.33
ITGA2B P08514 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23530342 0.95 TSHR (0.56) TSHRTHRBPOLBAPEX1HTT
SCHEMBL23530360 0.93 TSHR (0.59) TSHRTHRBPOLBAPEX1HTT
SCHEMBL23530388 0.93 TSHR (0.59) TSHRTHRBPOLBAPEX1HTT
SCHEMBL26306 0.89 THRB (0.48) TSHRTHRBPOLBAPEX1HTT
Hydrochloric Acid SCHEMBL1396466 0.87 THRB (0.47) TSHRTHRBPOLBAPEX1HTT
Bromide SCHEMBL11526296 0.87 THRB (0.47) TSHRTHRBPOLBAPEX1HTT
Fluoride SCHEMBL8582115 0.87 THRB (0.47) TSHRTHRBPOLBAPEX1HTT
SCHEMBL22187021 0.87 TSHR (0.47) TSHRTHRBPOLBAPEX1HTT
SCHEMBL28409145 0.85 TSHR (0.53) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5070605 0.84 TSHR (0.71) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12172382-B2 Methods for producing three-dimensional objects CARBON, INC. (US) 2024-12-24 US claimed
US-20240239948-A1 METHODS FOR THE RAPID PRODUCTION OF BLOCKED PREPOLYMERS CARBON INC (US) 2024-07-18 US claimed
EP-4347679-A1 METHODS FOR THE RAPID PRODUCTION OF BLOCKED PREPOLYMERS Carbon, Inc. (US) 2024-04-10 EP claimed
US-20240034000-A1 METHODS FOR PRODUCING THREE-DIMENSIONAL OBJECTS CARBON INC (US) 2024-02-01 US claimed
US-11859057-B2 Partially reversible thermosets useful for recycling CARBON, INC. (US) 2024-01-02 US claimed
US-11850803-B2 Methods for producing three-dimensional objects with apparatus having feed channels CARBON, INC. (US) 2023-12-26 US claimed
US-11717471-B2 Hydrogel microcapsules ISP INVESTMENTS LLC (US) 2023-08-08 US claimed
US-11655329-B2 Delayed action catalysts for dual cure additive manufacturing resins CARBON, INC. (US) 2023-05-23 US claimed
US-20230125915-A1 PARTIALLY REVERSIBLE THERMOSETS USEFUL FOR RECYCLING CARBON INC (US) 2023-04-27 US claimed
WO-2022256635-A1 METHODS FOR THE RAPID PRODUCTION OF BLOCKED PREPOLYMERS CARBON, INC. (US) 2022-12-08 WO claimed
WO-2019112707-A1 SHELF STABLE, LOW TIN CONCENTRATION, DUAL CURE ADDITIVE MANUFACTURING RESINS CARBON, INC. (US) 2019-06-13 WO claimed
EP-3390483-A1 ENCAPSULATION The Procter and Gamble Company (US) 2018-10-24 EP claimed
EP-3368207-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2018-09-05 EP claimed
US-20180235893-A1 ENCAPSULATION THE PROCTER & GAMBLE COMPANY 2018-08-23 US claimed
US-9937477-B2 Encapsulation WATERTITE PRODUCTS, INC. 2018-04-10 US claimed
WO-2017074995-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2017-05-04 WO claimed
WO-2017074997-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2017-05-04 WO claimed
US-20170113200-A1 Encapsulation Encapsys,LLC (US) 2017-04-27 US claimed
US-20130302392-A1 HYDROGEL MICROCAPSULES HERCULES LLC 2013-11-14 US claimed
US-20060181587-A1 Ink set and media for ink-jet printing HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2006-08-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11717471-B2 Hydrogel microcapsules MITF, DSG1, SHH TSHR 2621/4885THRB 3065/4885POLB 2927/4885
US-20180235893-A1 ENCAPSULATION ACR, ACMSD, SAMM50 TSHR 4720/4885THRB 3902/4885POLB 116/4885
US-20130302392-A1 HYDROGEL MICROCAPSULES MITF, DSG1, SHH TSHR 2621/4885THRB 3065/4885POLB 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.